| Schedule of Segment Information |
The following table is a summary of segment information for three months ended March 31, 2025 and 2024 (amounts in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
For the three months ended |
|
March 31, 2025 |
|
March 31, 2024 |
| Net revenues |
|
|
|
| Diagnostic services |
$ |
— |
|
|
$ |
— |
|
| Consumer products |
1,431 |
|
|
2,356 |
|
| Consolidated net revenue |
1,431 |
|
|
2,356 |
|
| Cost of revenue |
|
|
|
| Diagnostic services |
232 |
|
|
720 |
|
| Consumer products |
673 |
|
|
1,696 |
|
| Consolidated cost of revenue |
905 |
|
|
2,416 |
|
| Depreciation and amortization expense |
|
|
|
| Diagnostic services |
334 |
|
|
801 |
|
| Consumer products |
807 |
|
|
804 |
|
| Total Depreciation and amortization expense |
1,141 |
|
|
1,605 |
|
| Operating and other expenses |
|
|
|
| Diagnostic services |
168 |
|
|
1,824 |
|
| Consumer products |
1,061 |
|
|
1,115 |
|
| Unallocated corporate |
2,834 |
|
|
3,486 |
|
| Total operating and other expenses |
4,063 |
|
|
6,425 |
|
| Income (loss) from operations, before income taxes |
|
|
|
| Diagnostic services |
(734) |
|
|
(3,345) |
|
| Consumer products |
(1,110) |
|
|
(1,259) |
|
| Unallocated corporate |
(2,834) |
|
|
(3,486) |
|
| Total loss from operations, before income taxes |
(4,678) |
|
|
(8,090) |
|
| Income tax (expense) benefit |
— |
|
|
2,566 |
|
| Total loss from operations, after income taxes |
(4,678) |
|
|
(5,524) |
|
| Net loss from continuing operations |
$ |
(4,678) |
|
|
$ |
(5,524) |
|
The following table is a summary of segment information as of March 31, 2025 and December 31, 2024 (amounts in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31, 2025 |
|
December 31, 2024 |
| ASSETS |
|
|
|
| Diagnostic services |
$ |
25,516 |
|
|
$ |
26,069 |
|
| Consumer products |
18,712 |
|
|
19,745 |
|
| Unallocated corporate |
5,883 |
|
|
5,804 |
|
| Assets in discontinued operations |
— |
|
|
11,582 |
|
| Total assets |
$ |
50,111 |
|
|
$ |
63,200 |
|
|